世界の副腎皮質がん治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Adrenocortical Carcinoma Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z0109 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、副腎皮質がん治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（限局性副腎皮質がん、転移性副腎皮質がん）、用途別市場規模（病院、外来手術センター、クリニック、がん研究所）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・副腎皮質がん治療の市場動向 ・企業の競争状況、市場シェア ・副腎皮質がん治療の種類別市場規模（限局性副腎皮質がん、転移性副腎皮質がん） ・副腎皮質がん治療の用途別市場規模（病院、外来手術センター、クリニック、がん研究所） ・副腎皮質がん治療の北米市場規模2016-2027（アメリカ、カナダ） ・副腎皮質がん治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・副腎皮質がん治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・副腎皮質がん治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・副腎皮質がん治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（ArQule、EnGeneIC、Exelixis、Merck、Millendo Therapeutics、Orphagen Pharmaceuticals） ・結論

Adrenocortical carcinoma (ACC) is a rare disease caused by cancerous growth in the adrenal cortex, which is the outer layer of the adrenal glands. The adrenal glands lie on top of the kidneys. They play a major role in the endocrine system, which is the system that produces and regulates hormones. The causes of primary adrenocortical carcinoma are unknown. However adrenocortical carcinoma can also be secondary cancer. A secondary cancer is what happens when another form of cancer spreads to the adrenal glands. Adrenocortical carcinoma can occur at any age, but there is a bimodal distribution with a first peak at childhood between 1–6 years old and the second peak in the fourth to the fifth decade of life. During the past decade, collaborative efforts have been made to improve the ACC treatment. 
Some of the key factors that are driving the adrenocortical carcinoma treatment market are increasing the prevalence of cancer, rising government involvement, increasing funding from various government and non-government organizations. Also, ethical acceptance of adrenocortical carcinoma treatment and high unmet needs in some regions are driving the adrenocortical carcinoma treatment market. However, less awareness and high cost involved in treatment are restraining the global adrenocortical carcinoma treatment market. Also, the introduction of generic drugs in some countries is restraining the growth of adrenocortical carcinoma treatment market. Also, despite the high cost involved in R&D, pharmaceutical companies are showing increased interest in this field. This is expected to offer good potential for adrenocortical carcinoma treatment market.

Market Analysis and Insights: Global Adrenocortical Carcinoma Treatment Market
The global Adrenocortical Carcinoma Treatment market size is projected to reach US$ 595.6 million by 2026, from US$ 537 million in 2019, at a CAGR of 1.5% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Adrenocortical Carcinoma Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Adrenocortical Carcinoma Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Adrenocortical Carcinoma Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Adrenocortical Carcinoma Treatment market.

Global Adrenocortical Carcinoma Treatment Scope and Market Size
Adrenocortical Carcinoma Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Adrenocortical Carcinoma Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Localized Adrenocortical Carcinoma
Metastatic Adrenocortical Carcinoma

Segment by Application
Hospitals
Ambulatory Surgical Centers
Clinics
Cancer Research Institutes

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
ArQule
EnGeneIC
Exelixis
Merck
Millendo Therapeutics
Orphagen Pharmaceuticals

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Adrenocortical Carcinoma Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Localized Adrenocortical Carcinoma
1.2.3 Metastatic Adrenocortical Carcinoma
1.3 Market by Application
1.3.1 Global Adrenocortical Carcinoma Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Clinics
1.3.5 Cancer Research Institutes
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Adrenocortical Carcinoma Treatment Market Perspective (2016-2027)
2.2 Adrenocortical Carcinoma Treatment Growth Trends by Regions
2.2.1 Adrenocortical Carcinoma Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Adrenocortical Carcinoma Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Adrenocortical Carcinoma Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Adrenocortical Carcinoma Treatment Industry Dynamic
2.3.1 Adrenocortical Carcinoma Treatment Market Trends
2.3.2 Adrenocortical Carcinoma Treatment Market Drivers
2.3.3 Adrenocortical Carcinoma Treatment Market Challenges
2.3.4 Adrenocortical Carcinoma Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Adrenocortical Carcinoma Treatment Players by Revenue
3.1.1 Global Top Adrenocortical Carcinoma Treatment Players by Revenue (2016-2021)
3.1.2 Global Adrenocortical Carcinoma Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Adrenocortical Carcinoma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Adrenocortical Carcinoma Treatment Revenue
3.4 Global Adrenocortical Carcinoma Treatment Market Concentration Ratio
3.4.1 Global Adrenocortical Carcinoma Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Adrenocortical Carcinoma Treatment Revenue in 2020
3.5 Adrenocortical Carcinoma Treatment Key Players Head office and Area Served
3.6 Key Players Adrenocortical Carcinoma Treatment Product Solution and Service
3.7 Date of Enter into Adrenocortical Carcinoma Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Adrenocortical Carcinoma Treatment Breakdown Data by Type
4.1 Global Adrenocortical Carcinoma Treatment Historic Market Size by Type (2016-2021)
4.2 Global Adrenocortical Carcinoma Treatment Forecasted Market Size by Type (2022-2027)

5 Adrenocortical Carcinoma Treatment Breakdown Data by Application
5.1 Global Adrenocortical Carcinoma Treatment Historic Market Size by Application (2016-2021)
5.2 Global Adrenocortical Carcinoma Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Adrenocortical Carcinoma Treatment Market Size (2016-2027)
6.2 North America Adrenocortical Carcinoma Treatment Market Size by Type
6.2.1 North America Adrenocortical Carcinoma Treatment Market Size by Type (2016-2021)
6.2.2 North America Adrenocortical Carcinoma Treatment Market Size by Type (2022-2027)
6.2.3 North America Adrenocortical Carcinoma Treatment Market Size by Type (2016-2027)
6.3 North America Adrenocortical Carcinoma Treatment Market Size by Application
6.3.1 North America Adrenocortical Carcinoma Treatment Market Size by Application (2016-2021)
6.3.2 North America Adrenocortical Carcinoma Treatment Market Size by Application (2022-2027)
6.3.3 North America Adrenocortical Carcinoma Treatment Market Size by Application (2016-2027)
6.4 North America Adrenocortical Carcinoma Treatment Market Size by Country
6.4.1 North America Adrenocortical Carcinoma Treatment Market Size by Country (2016-2021)
6.4.2 North America Adrenocortical Carcinoma Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Adrenocortical Carcinoma Treatment Market Size (2016-2027)
7.2 Europe Adrenocortical Carcinoma Treatment Market Size by Type
7.2.1 Europe Adrenocortical Carcinoma Treatment Market Size by Type (2016-2021)
7.2.2 Europe Adrenocortical Carcinoma Treatment Market Size by Type (2022-2027)
7.2.3 Europe Adrenocortical Carcinoma Treatment Market Size by Type (2016-2027)
7.3 Europe Adrenocortical Carcinoma Treatment Market Size by Application
7.3.1 Europe Adrenocortical Carcinoma Treatment Market Size by Application (2016-2021)
7.3.2 Europe Adrenocortical Carcinoma Treatment Market Size by Application (2022-2027)
7.3.3 Europe Adrenocortical Carcinoma Treatment Market Size by Application (2016-2027)
7.4 Europe Adrenocortical Carcinoma Treatment Market Size by Country
7.4.1 Europe Adrenocortical Carcinoma Treatment Market Size by Country (2016-2021)
7.4.2 Europe Adrenocortical Carcinoma Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Adrenocortical Carcinoma Treatment Market Size (2016-2027)
8.2 Asia-Pacific Adrenocortical Carcinoma Treatment Market Size by Type
8.2.1 Asia-Pacific Adrenocortical Carcinoma Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Adrenocortical Carcinoma Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Adrenocortical Carcinoma Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Adrenocortical Carcinoma Treatment Market Size by Application
8.3.1 Asia-Pacific Adrenocortical Carcinoma Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Adrenocortical Carcinoma Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Adrenocortical Carcinoma Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Adrenocortical Carcinoma Treatment Market Size by Region
8.4.1 Asia-Pacific Adrenocortical Carcinoma Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Adrenocortical Carcinoma Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Adrenocortical Carcinoma Treatment Market Size (2016-2027)
9.2 Latin America Adrenocortical Carcinoma Treatment Market Size by Type
9.2.1 Latin America Adrenocortical Carcinoma Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Adrenocortical Carcinoma Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Adrenocortical Carcinoma Treatment Market Size by Type (2016-2027)
9.3 Latin America Adrenocortical Carcinoma Treatment Market Size by Application
9.3.1 Latin America Adrenocortical Carcinoma Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Adrenocortical Carcinoma Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Adrenocortical Carcinoma Treatment Market Size by Application (2016-2027)
9.4 Latin America Adrenocortical Carcinoma Treatment Market Size by Country
9.4.1 Latin America Adrenocortical Carcinoma Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Adrenocortical Carcinoma Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Adrenocortical Carcinoma Treatment Market Size (2016-2027)
10.2 Middle East & Africa Adrenocortical Carcinoma Treatment Market Size by Type
10.2.1 Middle East & Africa Adrenocortical Carcinoma Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Adrenocortical Carcinoma Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Adrenocortical Carcinoma Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Adrenocortical Carcinoma Treatment Market Size by Application
10.3.1 Middle East & Africa Adrenocortical Carcinoma Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Adrenocortical Carcinoma Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Adrenocortical Carcinoma Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Adrenocortical Carcinoma Treatment Market Size by Country
10.4.1 Middle East & Africa Adrenocortical Carcinoma Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Adrenocortical Carcinoma Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 ArQule
11.1.1 ArQule Company Details
11.1.2 ArQule Business Overview
11.1.3 ArQule Adrenocortical Carcinoma Treatment Introduction
11.1.4 ArQule Revenue in Adrenocortical Carcinoma Treatment Business (2016-2021)
11.1.5 ArQule Recent Development
11.2 EnGeneIC
11.2.1 EnGeneIC Company Details
11.2.2 EnGeneIC Business Overview
11.2.3 EnGeneIC Adrenocortical Carcinoma Treatment Introduction
11.2.4 EnGeneIC Revenue in Adrenocortical Carcinoma Treatment Business (2016-2021)
11.2.5 EnGeneIC Recent Development
11.3 Exelixis
11.3.1 Exelixis Company Details
11.3.2 Exelixis Business Overview
11.3.3 Exelixis Adrenocortical Carcinoma Treatment Introduction
11.3.4 Exelixis Revenue in Adrenocortical Carcinoma Treatment Business (2016-2021)
11.3.5 Exelixis Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Adrenocortical Carcinoma Treatment Introduction
11.4.4 Merck Revenue in Adrenocortical Carcinoma Treatment Business (2016-2021)
11.4.5 Merck Recent Development
11.5 Millendo Therapeutics
11.5.1 Millendo Therapeutics Company Details
11.5.2 Millendo Therapeutics Business Overview
11.5.3 Millendo Therapeutics Adrenocortical Carcinoma Treatment Introduction
11.5.4 Millendo Therapeutics Revenue in Adrenocortical Carcinoma Treatment Business (2016-2021)
11.5.5 Millendo Therapeutics Recent Development
11.6 Orphagen Pharmaceuticals
11.6.1 Orphagen Pharmaceuticals Company Details
11.6.2 Orphagen Pharmaceuticals Business Overview
11.6.3 Orphagen Pharmaceuticals Adrenocortical Carcinoma Treatment Introduction
11.6.4 Orphagen Pharmaceuticals Revenue in Adrenocortical Carcinoma Treatment Business (2016-2021)
11.6.5 Orphagen Pharmaceuticals Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Adrenocortical Carcinoma Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Localized Adrenocortical Carcinoma
Table 3. Key Players of Metastatic Adrenocortical Carcinoma
Table 4. Global Adrenocortical Carcinoma Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Adrenocortical Carcinoma Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Adrenocortical Carcinoma Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Adrenocortical Carcinoma Treatment Market Share by Regions (2016-2021)
Table 8. Global Adrenocortical Carcinoma Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Adrenocortical Carcinoma Treatment Market Share by Regions (2022-2027)
Table 10. Adrenocortical Carcinoma Treatment Market Trends
Table 11. Adrenocortical Carcinoma Treatment Market Drivers
Table 12. Adrenocortical Carcinoma Treatment Market Challenges
Table 13. Adrenocortical Carcinoma Treatment Market Restraints
Table 14. Global Adrenocortical Carcinoma Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Adrenocortical Carcinoma Treatment Market Share by Players (2016-2021)
Table 16. Global Top Adrenocortical Carcinoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Adrenocortical Carcinoma Treatment as of 2020)
Table 17. Ranking of Global Top Adrenocortical Carcinoma Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Adrenocortical Carcinoma Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Adrenocortical Carcinoma Treatment Product Solution and Service
Table 21. Date of Enter into Adrenocortical Carcinoma Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Adrenocortical Carcinoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Adrenocortical Carcinoma Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Adrenocortical Carcinoma Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Adrenocortical Carcinoma Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Adrenocortical Carcinoma Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Adrenocortical Carcinoma Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Adrenocortical Carcinoma Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Adrenocortical Carcinoma Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Adrenocortical Carcinoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Adrenocortical Carcinoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Adrenocortical Carcinoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Adrenocortical Carcinoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Adrenocortical Carcinoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Adrenocortical Carcinoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Adrenocortical Carcinoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Adrenocortical Carcinoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Adrenocortical Carcinoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Adrenocortical Carcinoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Adrenocortical Carcinoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Adrenocortical Carcinoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Adrenocortical Carcinoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Adrenocortical Carcinoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Adrenocortical Carcinoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Adrenocortical Carcinoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Adrenocortical Carcinoma Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Adrenocortical Carcinoma Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Adrenocortical Carcinoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Adrenocortical Carcinoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Adrenocortical Carcinoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Adrenocortical Carcinoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Adrenocortical Carcinoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Adrenocortical Carcinoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Adrenocortical Carcinoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Adrenocortical Carcinoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Adrenocortical Carcinoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Adrenocortical Carcinoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Adrenocortical Carcinoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Adrenocortical Carcinoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. ArQule Company Details
Table 62. ArQule Business Overview
Table 63. ArQule Adrenocortical Carcinoma Treatment Product
Table 64. ArQule Revenue in Adrenocortical Carcinoma Treatment Business (2016-2021) & (US$ Million)
Table 65. ArQule Recent Development
Table 66. EnGeneIC Company Details
Table 67. EnGeneIC Business Overview
Table 68. EnGeneIC Adrenocortical Carcinoma Treatment Product
Table 69. EnGeneIC Revenue in Adrenocortical Carcinoma Treatment Business (2016-2021) & (US$ Million)
Table 70. EnGeneIC Recent Development
Table 71. Exelixis Company Details
Table 72. Exelixis Business Overview
Table 73. Exelixis Adrenocortical Carcinoma Treatment Product
Table 74. Exelixis Revenue in Adrenocortical Carcinoma Treatment Business (2016-2021) & (US$ Million)
Table 75. Exelixis Recent Development
Table 76. Merck Company Details
Table 77. Merck Business Overview
Table 78. Merck Adrenocortical Carcinoma Treatment Product
Table 79. Merck Revenue in Adrenocortical Carcinoma Treatment Business (2016-2021) & (US$ Million)
Table 80. Merck Recent Development
Table 81. Millendo Therapeutics Company Details
Table 82. Millendo Therapeutics Business Overview
Table 83. Millendo Therapeutics Adrenocortical Carcinoma Treatment Product
Table 84. Millendo Therapeutics Revenue in Adrenocortical Carcinoma Treatment Business (2016-2021) & (US$ Million)
Table 85. Millendo Therapeutics Recent Development
Table 86. Orphagen Pharmaceuticals Company Details
Table 87. Orphagen Pharmaceuticals Business Overview
Table 88. Orphagen Pharmaceuticals Adrenocortical Carcinoma Treatment Product
Table 89. Orphagen Pharmaceuticals Revenue in Adrenocortical Carcinoma Treatment Business (2016-2021) & (US$ Million)
Table 90. Orphagen Pharmaceuticals Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Adrenocortical Carcinoma Treatment Market Share by Type: 2020 VS 2027
Figure 2. Localized Adrenocortical Carcinoma Features
Figure 3. Metastatic Adrenocortical Carcinoma Features
Figure 4. Global Adrenocortical Carcinoma Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Ambulatory Surgical Centers Case Studies
Figure 7. Clinics Case Studies
Figure 8. Cancer Research Institutes Case Studies
Figure 9. Adrenocortical Carcinoma Treatment Report Years Considered
Figure 10. Global Adrenocortical Carcinoma Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Adrenocortical Carcinoma Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Adrenocortical Carcinoma Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Adrenocortical Carcinoma Treatment Market Share by Regions (2022-2027)
Figure 14. Global Adrenocortical Carcinoma Treatment Market Share by Players in 2020
Figure 15. Global Top Adrenocortical Carcinoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Adrenocortical Carcinoma Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Adrenocortical Carcinoma Treatment Revenue in 2020
Figure 17. Global Adrenocortical Carcinoma Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Adrenocortical Carcinoma Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Adrenocortical Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Adrenocortical Carcinoma Treatment Market Share by Type (2016-2027)
Figure 21. North America Adrenocortical Carcinoma Treatment Market Share by Application (2016-2027)
Figure 22. North America Adrenocortical Carcinoma Treatment Market Share by Country (2016-2027)
Figure 23. United States Adrenocortical Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Adrenocortical Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Adrenocortical Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Adrenocortical Carcinoma Treatment Market Share by Type (2016-2027)
Figure 27. Europe Adrenocortical Carcinoma Treatment Market Share by Application (2016-2027)
Figure 28. Europe Adrenocortical Carcinoma Treatment Market Share by Country (2016-2027)
Figure 29. Germany Adrenocortical Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Adrenocortical Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Adrenocortical Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Adrenocortical Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Adrenocortical Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Adrenocortical Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Adrenocortical Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Adrenocortical Carcinoma Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Adrenocortical Carcinoma Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Adrenocortical Carcinoma Treatment Market Share by Region (2016-2027)
Figure 39. China Adrenocortical Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Adrenocortical Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Adrenocortical Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Adrenocortical Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Adrenocortical Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Adrenocortical Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Adrenocortical Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Adrenocortical Carcinoma Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Adrenocortical Carcinoma Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Adrenocortical Carcinoma Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Adrenocortical Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Adrenocortical Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Adrenocortical Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Adrenocortical Carcinoma Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Adrenocortical Carcinoma Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Adrenocortical Carcinoma Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Adrenocortical Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Adrenocortical Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Adrenocortical Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. ArQule Revenue Growth Rate in Adrenocortical Carcinoma Treatment Business (2016-2021)
Figure 59. EnGeneIC Revenue Growth Rate in Adrenocortical Carcinoma Treatment Business (2016-2021)
Figure 60. Exelixis Revenue Growth Rate in Adrenocortical Carcinoma Treatment Business (2016-2021)
Figure 61. Merck Revenue Growth Rate in Adrenocortical Carcinoma Treatment Business (2016-2021)
Figure 62. Millendo Therapeutics Revenue Growth Rate in Adrenocortical Carcinoma Treatment Business (2016-2021)
Figure 63. Orphagen Pharmaceuticals Revenue Growth Rate in Adrenocortical Carcinoma Treatment Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

---